Structured page family:Cost guide

Abaloparatide Cost Guide: Insurance, Cash Pay, and Savings

In the United States, Abaloparatide costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.

Active Market
This page is designed for US treatment decisions and uses US-first pricing and savings sources.
Official pricing
Verify current pricing directly on official Tymlos pages before starting, because list pricing, self-pay offers, and eligibility terms can change.
Cash-pay reality
Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.
Insurance coverage
Commercial coverage for Abaloparatide varies by plan and indication. Prior authorization is commonly required.
Savings and coupons
Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.
Prior Authorization
Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.

Price Breakdown

List price (monthly)
~$3,500-$4,000/month
Average wholesale price
~$3,200-$3,800/month
Pharmacy acquisition estimate
~$3,000-$3,500/month
Typical negotiated rate
~$2,200-$2,800/month
Price per dose
~$117 per 80 mcg
Annual cost at list price
~$42,000-$48,000

Pharmacy Price Comparison

PharmacyPrice RangeNotes
Specialty pharmacy$3,200-$4,000/monthRequired

Insurance Coverage Landscape

Commercial plans
~70-85% with documentation
Medicare Part D
Covered
Medicaid
Most states cover with prior auth
VA coverage
On formulary
TRICARE
Covered with prior auth
Employer plan typical tier
Tier 4-5 specialty; coinsurance 25-40%

Prior Authorization Guide

Required Documentation
  • DXA T-score ≤-2.5 with fracture or T-score ≤-3.0
  • Bisphosphonate failure or intolerance (often required)
  • Recent DXA
  • Fracture documentation
Common Denial Reasons
  • No fracture history
  • Bisphosphonate not tried
  • T-score not severe enough
Appeal Template Points
  • Severe osteoporosis
  • Bisphosphonate failure
  • High fracture risk
  • Anabolic therapy indicated
Expected timeline: 1-2 weeks

Savings Programs and Patient Assistance

Tymlos PAP
manufacturer
Eligibility: Uninsured, ≤400% FPL
Savings: Free
Income limit: ≤400% FPL
Enrollment: moderate
Radius Health program
Savings card
copay
Eligibility: Commercially insured
Savings: May reduce significantly
Income limit: None
Enrollment: simple
Annual cap

Generic and Biosimilar Status

No generic currently available
Expected: No generic expected before patent expiry

Cost by Dose

Dose/RegimenMonthlyAnnual
80 mcg daily$3,500-$4,000$42,000-$48,000

Annual Cost Projection

Year 1
$0-$48,000
Year 2
$0-$48,000
Year 3
$0 (transition to antiresorptive)
Assumptions
  • 2-year limit
  • Insurance/PAP

Cost-Saving Strategies

  • 1.Apply for PAP if uninsured
  • 2.Document bisphosphonate failure thoroughly
  • 3.Compare to teriparatide pricing — may be similar
  • 4.Plan for antiresorptive continuation cost after 2 years

International Price Comparison

CountryPrice RangeNotes
UK~£250-350/month (~$320-450)NHS

Need help comparing abaloparatide paths?

Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.

Find a abaloparatide provider
Trust Summary
Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 2 official sources.
Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.

Abaloparatide Cost FAQ

Sources

  1. 1. Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.
    J Clin Endocrinol Metab • 2020
    Claim type: clinical
    View source →
  2. 2. FDA Information on Abaloparatide
    FDA • 2026
    Claim type: regulatory
    View source →

This content is for informational purposes only and does not constitute medical advice.